Salivary autoantibodies to type I IFNs: Mirror plasma levels, predispose to severe COVID-19, and enhance feasibility for clinical screening.
Saved in:
| Title: | Salivary autoantibodies to type I IFNs: Mirror plasma levels, predispose to severe COVID-19, and enhance feasibility for clinical screening. |
|---|---|
| Authors: | Saheb Sharif-Askari N; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates., Saheb Sharif-Askari F; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates; Department of pharmacy practice and pharmacotherapeutics, College of pharmacy, University of Sharjah, Sharjah, United Arab Emirates., Bayram OS; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates., Hafezi S; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates., Alsayed HAH; Department of Pharmacy, Rashid Hospital, Dubai Academic Health Corporation, Dubai, United Arab Emirates., Kasim F; Department of internal medicine, Zulekha Hospitals, Dubai, United Arab Emirates., Mdkhana B; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates., Selvakumar B; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates., Alsafar HS; Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates; Department of Biomedical Engineering, College of Engineering, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates; Department of Genetics and Molecular Biology, College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates., Halwani R; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; Prince Abdullah Ben Khaled Celiac Disease Research Chair, department of pediatrics, Faculty of Medicine, King Saud University, Saudi Arabia. Electronic address: rhalwani@sharjah.ac.ae. |
| Source: | Heart & lung : the journal of critical care [Heart Lung] 2024 Jun-Aug; Vol. 66, pp. 31-36. Date of Electronic Publication: 2024 Mar 27. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Mosby Country of Publication: United States NLM ID: 0330057 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3288 (Electronic) Linking ISSN: 01479563 NLM ISO Abbreviation: Heart Lung Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38547583 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Salivary autoantibodies to type I IFNs: Mirror plasma levels, predispose to severe COVID-19, and enhance feasibility for clinical screening. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Saheb+Sharif-Askari+N%22">Saheb Sharif-Askari N</searchLink>; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Saheb+Sharif-Askari+F%22">Saheb Sharif-Askari F</searchLink>; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates; Department of pharmacy practice and pharmacotherapeutics, College of pharmacy, University of Sharjah, Sharjah, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Bayram+OS%22">Bayram OS</searchLink>; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Hafezi+S%22">Hafezi S</searchLink>; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Alsayed+HAH%22">Alsayed HAH</searchLink>; Department of Pharmacy, Rashid Hospital, Dubai Academic Health Corporation, Dubai, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Kasim+F%22">Kasim F</searchLink>; Department of internal medicine, Zulekha Hospitals, Dubai, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Mdkhana+B%22">Mdkhana B</searchLink>; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Selvakumar+B%22">Selvakumar B</searchLink>; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Alsafar+HS%22">Alsafar HS</searchLink>; Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates; Department of Biomedical Engineering, College of Engineering, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates; Department of Genetics and Molecular Biology, College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Halwani+R%22">Halwani R</searchLink>; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; Prince Abdullah Ben Khaled Celiac Disease Research Chair, department of pediatrics, Faculty of Medicine, King Saud University, Saudi Arabia. Electronic address: rhalwani@sharjah.ac.ae. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220330057%22">Heart & lung : the journal of critical care</searchLink> [Heart Lung] 2024 Jun-Aug; Vol. 66, pp. 31-36. <i>Date of Electronic Publication: </i>2024 Mar 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Mosby%22">Mosby </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0330057 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-3288 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201479563%22">01479563 </searchLink><i>NLM ISO Abbreviation: </i>Heart Lung <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38547583 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.hrtlng.2024.03.005 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 31 Titles: – TitleFull: Salivary autoantibodies to type I IFNs: Mirror plasma levels, predispose to severe COVID-19, and enhance feasibility for clinical screening. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Saheb Sharif-Askari N – PersonEntity: Name: NameFull: Saheb Sharif-Askari F – PersonEntity: Name: NameFull: Bayram OS – PersonEntity: Name: NameFull: Hafezi S – PersonEntity: Name: NameFull: Alsayed HAH – PersonEntity: Name: NameFull: Kasim F – PersonEntity: Name: NameFull: Mdkhana B – PersonEntity: Name: NameFull: Selvakumar B – PersonEntity: Name: NameFull: Alsafar HS – PersonEntity: Name: NameFull: Halwani R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2024 Jun-Aug Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1527-3288 Numbering: – Type: volume Value: 66 Titles: – TitleFull: Heart & lung : the journal of critical care Type: main |
| ResultId | 1 |